Hypo-RESOLVE
Hypoglycaemia - REdefining SOLutions for better liVEs
- Description
Diabetes is a global pandemic affecting around 60 million people in Europe. As a common and serious complication, Hypoglycaemia is particularly affecting people with diabetes on insulin therapy and can lead to cognitive decline, cardiovascular events and even death. Within Hypo-RESOLVE, 23 international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia in diabetes.
- Coordinator
- Dr Bastiaan de GalanStichting Radboud Universitair Medisch Centrum (RADBOUDUMC)Phone: 31243618819Email
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 66 months (May 2018 - October 2023)
- Project funding
- € 26,800,000.00
- Project partners
- 23
- Technology readiness level
- 0-2